Literature DB >> 6295997

Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime.

D Cable, G Edralin, G D Overturf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295997     DOI: 10.1093/jac/10.suppl_c.121

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].

Authors:  O Brückner; M Trautmann
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 2.  Cephalosporins in the treatment of meningitis.

Authors:  H C Neu
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 4.  Bacterial meningitis. Rational selection and use of antibacterial drugs.

Authors:  M Whitby; R Finch
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

5.  Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis.

Authors:  D Cable; G Overturf; G Edralin
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 7.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.